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Abstract: 
R-spondin 4 is a secreted protein mainly associated with embryonic nail development. R-spondins have been recently 
identified as heparin-binding proteins with high affinity. Proteoglycan binding has been associated with both the TSR and 
the C terminal basic amino acid rich domains. In this paper, molecular modeling techniques were used to construct the model 
of R-spondin 4 TSR domain based on the structure of the F-spondin TSR domain 4 (30-40% sequence identity). Beside a 
positively charged surface in the TSR domain, presence of the basic amino acid rich domain which could forms a continuous 
heparin binding surface may explain the high affinity of R-spondins for heparin. Our results provide a framework for 
understanding the possible regulatory role of heparin in R-spondins signalling. 
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Background: 
R-spondin 4 gene plays a key role in the embryonic nail 
development. Recent reports identified R-spondin 4 gene 
as responsible for congenital anonychia which is a rare 
autosomal-recessive disorder characterized by the absence 
of finger and toenails [1]. The human R-spondin 4 protein 
gene, member of R-spondin family (R-spondin 1-4), 
consists of five coding exons corresponding to predicted 
structural domains. Predicted domains include the N-
terminal signal peptide sequences encoded by exon 1, the 
two adjacent cysteine rich furin like domains encoded by 
exon 2 and 3 and the single thrombospondin TSP1 domain 
that is encoded by exon 4. The C terminal basic region 
encoded by exon 5 is of varying length and scores as a 
nuclear localization signal [1]. 
 
The two cysteine rich domains are thought to be 
responsible for binding to the wnt signalling pathway. 
Recent reports have suggested that the R-spondin plays a 
positive modulatory role in Wnt ligand activity presumably 
by directly interacting with Wnt ligands [1] and [2]. The 
thrombospondin TSP 1 domain (designated TSP-1 domain 
in the pfam database or TSR elsewhere) was found for the 
first time in the thrombospondin protein where it is 
repeated three times [3]. Since then, the TSR domain has 
been identified within numerous protein families like 
complement factors, TRAP proteins of Plasmodium and F-
spondin. No single function is attributable to all TSRs. 
TSR has been involved in the regulation of cell 
proliferation, migration and apoptosis in a variety of 
physiological and pathological settings, such as wound 
healing, inflammation and angiogenesis [4]. 
 
The TSR domains (≈ 60 amino acids) are characterized by 
conserved Cys, Trp and Arg residues. The NH2-terminal 
portion of the TSR domain contains two or three 
tryptophan residues separated by two to four amino acids 
each [5]. Most TSRs have six cysteine residues; however, 
those found in some complement factors and in the malaria 
proteins contain less cysteine. 
 
The TSR and the basic amino residues rich domains were 
recently shown to be responsible for binding of R-spondin 
to heparin or HSPGs (heparan sulfate proteoglycans) [2]. 
HSPG have numerous biological functions. They are found 
predominantly at the cell surface and in the extracellular 
matrix, where they mediate cell interactions and modulate 
growth factor binding and activity [6].  
 
The three-dimensional structure of R-spondin 4 has not 
been determined until now and the structural study of its 
TSR domain may provide additional information about its 
molecular recognition of heparin. In this article, we present 
a model of the human R-spondin 4 TSR domain generated 
using molecular modelling techniques. Sequence analysis 
within the resulting structural model allowed the 
characterization of essential features of TSRs (namely the 
conserved tryptophans, arginines, and cysteines) and the 
prediction of a glycosaminoglycan binding site within this 
domain. 
 
Methodology: 
Template selection 
The human R-spondin 4 TSR domain (residues from 138 
to 197) (accession number Q2I0M5), was submitted to 
PDB-Blast  [7] and fold recognition servers 
(mGenTHREADER  [8] and PHYRE [9]) separately. 
Inspection of the template-target alignment generated by 
these servers shows that the best ranked templates belong 
to the same group within the TSR family. All cysteine 
residues in the template-target alignment produced by 
PHYRE were conserved in number and position. So this 
latter alignment was chosen for model building. Bioinformation by Biomedical Informatics Publishing Group                             open access 
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Figure 1: Multiple sequence alignment of human R-spondin 4 TSR domain, F-spondin TSR domains (1, 2, 3, 4 and 5), 
Thrombospondin  Related  Anonymous  Protein (TRAP) from Plasmodium falciparum TSR domain and human 
Thrombospondin-1 (TSP-1) TSR domains (1, 2 and 3). The potential locations of disulfide bonds are shown above the 
alignment (F-spondin group) and below it (TSP-1 group). Tryptophan, arginine residues forming CWR layered structure are 
highlighted in grey. Cysteine residues implicated in disulfide bond formation are highlighted in black. 
 
Model building, evaluation and structural analysis 
The predicted model was constructed using the 
MODELLER program [10] based both on the structure of 
F-spondin TSR domain 4 (pdb: 1vex) [11] and the 
alignment generated by PHYRE program. The model 
obtained was analyzed by Ramachandran's map using 
PROCHECK [12]. Structural analysis was performed and 
figures representations were generated with 
SwissPDBViewer [13]. 
 
Multiple sequence alignment  
The Multiple sequence alignment was constructed by 
aligning the TSR domains of human R-spondin 4, the TSR 
domains 1, 2, 3, 4 and 5 of human F-spondin (Q9HCB6), 
the TSR domain of TRAP from Plasmodium falciparum 
(P16893) and the TSR domains 1, 2 and 3 of human 
Thrombospondin-1 (P07996). The alignment using the 
ClustalW tool [14] was obtained on the basis of the 
conservation of the six cysteines as suggested previously 
[15]. Manual adjustments based on PHYRE results were 
performed and the result was shown in Figure 1. 
 
Electrostatic potential calculations  
The electrostatic potential was calculated with the Poisson-
Boltzmann module of SwissPDBViewer utilizing the 
following parameters: solvent dielectric constant of 80 and 
protein dielectric constant of 4. The electrostatic potential 
was then mapped to the molecular surface with a solvent 
probe radius of 1.4 Å.  In figure 3, Blue, white and red 
colors indicate positive neutral and negative electrostatic 
potential.  
 
Results and discussion: 
Structural analysis 
To create a model of R-spondin 4 TSR domain, we 
submitted the R-spondin 4 sequence (from residue 138 to 
residue 197) to PDB-Blast, mGenTHREADER and 
PHYRE servers. The BLAST search against the structures 
in Protein Data Bank (PDB) identified the F-spondin TSR 
domain 4 (pdb: 1vex) as the best hit with sequence identity 
of 30%. MGenTHREADER identified TSR domain of 
malaria TRAP protein (pdb: 2bbx), F-spondin TSR domain 
4 (pdb: 1vex), and F-spondin TSR domain 1 (pdb: 1szl) as 
top hits with 40.8, 32.1 and 24% of sequence identity 
respectively while PHYRE server scored the F-spondin 
TSR domain 4 (pdb: 1vex) as the best template with a 
lower E-value (1.7e-07) and   32 % sequence identity.  
 
The multiple sequence alignment (Figure 1) shows that the 
disulfide bond pattern within the TSR R-spondin 4 is the 
same as that found in F-spondin rather than that found in   
TSP-1. These latter's comprise the two major group of the 
TSR family. The disulfide bond pattern in group 1 (TSP-1) 
and group 2 (F-spondin) differ mainly by the N-terminal 
disulfide bond. In group 1, the bond is formed between 
cysteines within loop between strand B and C. 
 
In group 2 which is the group of F-spondin (a matrix-
associated protein expressed in
 the floor plate and involved 
mainly in the neuronal development), one cysteine resides 
in the loop and the other one in the N-terminal part of the 
sequence. For these reasons, the F-spondin TSR domain 4 
from Rattus norvegicus (1vex) [11] was selected as 
template to construct the model of R-spondin 4 TSR 
domain.  
 
The stereo-chemical quality of the R-spondin 4 TSR model 
was assessed by PROCHECK, which assigned 77.6 % of 
the residues to the Ramachandran's plot most-favoured 
regions, 22 % to additionally allowed regions. No residue 
was found in the generously allowed or in disallowed 
regions. PROCHECK result is roughly comparable to the 
corresponding statistics for the structure of F-spondin TSR 
domain 4 (data not shown).
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Figure 2: Predicted 3D model of the R-spondin 4 TSR domain. Tryptophan, arginine, and cysteine side chain forming CWR 
layered structure are shown in dark. The three strands and the two termini are marked with capital letters. 
 
 
Figure 3: Electrostatic potential surface representation of the R-spondin 4 TSR domain (front face) with positively charged 
residues labeled. Bioinformation by Biomedical Informatics Publishing Group                             open access 
www.bioinformation.net                                                              Hypothesis 
___________________________________________________________________________ 
 
ΙSSN 0973-2063 (online) 0973-2063 (print)                                                                             
Bioinformation 3(2): 119-123 (2008) 
Bioinformation, an open access forum 
© 2008 Biomedical Informatics Publishing Group 
122
The resulting model (Figure 2) reveals an architecture 
composed by three antiparallel strands. The first strand (A 
strand) is irregular, strands B and C form regular β-sheets 
(Gly162-Arg166) and (Glu186-Cys190 respectively). The 
fold of the TSR domain is characterized by a cysteine, 
tryptophan, and arginine residues from the three strands 
stacked in layers (the CWR layer) and by multiple 
hydrogen bonds between backbone and side chain atoms. 
 
The side chain of two tryptophans (Trp144 and Trp147) 
make up two tryptophans layers (the W layers) and play a 
central role in the fold. Two arginines (Arg166 and 
Arg168) comprise the R layers and their guanidinium 
groups are alternately stacked between W layers. The 
alternate stacking of the planar cationic guanidinium 
groups of the arginines and the aromatic side chains of the 
tryptophans forms three possible cation-Π interactions 
between (Arg166-Trp144, Arg168-Trp144 and Arg188-
Trp147) which may provide a vital stabilization in the 
structure as estimated by CAPTURE program [16]. 
Additional stability is brought to the structure by three 
disulfide bonds one on the N-terminal side (Cys139-
Cys180) and two on the C-terminal side (Cys150-Cys190 
and Cys157-Cys196) forming the C layer. Altogether the 
tryptophan, arginine, and cysteine side-chains form a 
seven-layered stacked structure. 
 
Glycosylation is one of the most abundant and widespread 
post-translational modifications of proteins. This 
modification involves the attachment of an alpha-mannosyl 
residue to the C-2 atom of the tryptophan residue. The Trp 
residues occur in WXXW patterns, which are the 
recognition motifs for protein C-mannosylation [17]. 
 
The TSR R-spondin 4 has been examined for the presence 
of C-mannosylation sites and was submitted to NetCGlyc 
1.0 available at http://www.cbs.dtu.dk/services/. Results 
show that tryptophan 144 and 147 residues are predicted to 
be C-mannosylated. 
 
The O-fucosylation which is a direct addition of O-fucose 
to serine or threonine is the second type of glycosylation 
found in TSR domains. The R spondin 4 sequence does not 
completely match the consensus sequence of 
WX5C
1X2/3(S/T) C2X2G [18] since it contains 5 amino 
acids between the C
1 and S/T instead of 2 or 3 amino acids. 
Furthermore, Hofsteenge and colleagues [18] showed that 
TSRs containing a positively charged residue at position 
immediately prior to the predicted modification site (Ser or 
Thr) were not O-fucosylated. 
 
Heparin binding prediction 
An electrostatic potential map was generated with utilities 
in DeepView/Swiss PDB Viewer [13]. As shown in Figure 
3, the molecular surface shows that the TSR domain of R-
spondin 4 contains a large positive charge from the N-
terminal side through the central cavity, due to basic amino 
acids. This is concurrent with the presence of exposed 
tryptophans from the W layers along with the exposed 
arginines (Arg166 and Arg168) from the R layers. Other 
residues that are located at the edge of the C (Arg188, 
Lys189) strand also help to create a groove-like structure 
within this positively charged region. 
A similar side chain array of conserved arginine and 
tryptophan side chains has been observed in the structures 
of TSP-1 as well as in F-spondin and TRAP TSRs [19]. 
These TSRs domains have a relatively low affinity for 
heparin suggesting that other residues may contribute 
significantly to the heparin binding.  
 
In fact, Nam and colleagues [2] showed that besides the 
TSR domain, the C terminal basic amino acid rich domain 
is also required for heparin binding. Although the study of 
this domain was not straightforward, analysis of the 
primary protein sequence of this basic rich domain 
revealed the existence of clusters of basic amino acids, that 
matches the consensus sequence for heparin binding 
(XBBX where B is basic and X is hydropathic (neutral and 
hydrophobic) amino acid [20]). It is feasible that the TSR 
domain and basic amino acid rich domains of R-spondin 4 
could form a continuous binding surface for heparin. 
Similarly, the affinity for heparin of the whole extracellular 
domain of TRAP (formed by TSR and A-domain) is twice 
that of TRAP A domain alone.  
 
The  5th and 6th TSRs of F-spondin (containing eight 
domains, six of them are TSR) involved in the attachment 
to the extracellular matrix of F-spondin by binding to 
protoglycans, have more amino acid basic residues on the 
front face  than that of F-spondin TSR domains 1-4 (more 
amino acid basic residues on the C strand and BC loop). 
 
On the other hand, a search with PredictNLS algorithm 
(available at 
http://cubic.bioc.columbia.edu/cgi/var/nair/resonline.pl) 
identified the fragment QKKGRKDRRPRKDRKLDRRL 
from 204 to 223 as Nuclear Localization Signal sequence. 
Involvement of this basic region in the heparin binding 
may suggest the implication of heparin in the penetration 
and nuclear uptake of R-spondin 4. Several studies have 
suggested the role of heparin in regulating nuclear 
internalization of growth factors such as FGF-1 and FGF-2 
[21]. Further studies should
 be carried out to substantiate 
these suggestions. 
 
Conclusion: 
In this paper the seven CWR layered model of R-spondin 4 
TSR domain was constructed on the base of similarity to F-
spondin TSR domain 4. The positively charged surface in 
the TSR domain and the contiguous basic amino acid rich 
region were predicted to form a continuous binding surface 
for heparin which may explain the high affinity of R-
spondin for heparin. Our results suggest that the binding is 
largely electrostatic in nature. 
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